NCT03478826

Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 635 (estimated)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.

Detailed description

The proposed biospecimen repository would be derived from patients diagnosed with ILD. This is to include 500 patients in the repository, with each patient contributing one blood sample. Patients with pneumonia and healthy patients will also be recruited as a control group.

Conditions

• Interstitial Lung Disease

Interventions

Type	Name	Description
OTHER	ILD	100 cc of blood collected from a total of 250 ILD patients. This includes IPF (n=100), fibrotic NSIP (n=50), chronic hypersensitivity pneumonia (n=20), sarcoidosis(n=50), progressive rheumatoid lung disease (n=10) and scleroderma lung disease (n=20)), 10 patients with other fibrosing disease (fibrosing mediastinitis), and 50 patients with lymphangioleiomyomatosis
OTHER	Healthy	100 cc of blood collected from a total of 25 healthy volunteers in order to compare with the ILD participants.
OTHER	Pneumonia	100 cc of blood collected from a total of 100 participants with a diagnosis of pneumonia in order to compare with the ILD participants.

Timeline

• Start date: 2018-08-01
• Primary completion: 2028-01-01
• Completion: 2028-01-01
• First posted: 2018-03-27
• Last updated: 2025-04-27

Locations

1 site across 1 country: United States